Abaxis, Inc. (NASDAQ:ABAX) reported preliminary financial results for Q3

Abaxis, Inc. (NASDAQ:ABAX) reported preliminary financial results for the third fiscal quarter ended December 31, 2016. Abaxis expects revenues in the third fiscal quarter of $52.0 million to $53.0 million, flat with last year’s comparable quarter. In addition, Abaxis expects operating income in the third fiscal quarter of $10.0 million to $11.0 million compared to $11.3 million in last year’s third quarter. Abaxis expects its gross margin for the third fiscal quarter to be between 55% and 56%.

Abaxis, Inc. (NASDAQ:ABAX) traded 784948 shares and was closed at $48.59 per share. The current share price indicates that stock is -13.15% away from its one year high and is moving 30.21% ahead of its one year low. Stock monthly performance is recorded as -9.67% while its performance in last 5 sessions is -9.40%.

Analyst’s Analysis on Abaxis, Inc. (NASDAQ:ABAX)

At the movement stock is under coverage by number of analysts. 1 given Buy rating to the stock whereas 1 analyst given UNDERPERFORM rating to stock and 5 analysts given HOLD rating. The consensus recommendation by Thomson Reuters analysts is Hold and their mean rating for the stock is 3.00 on scale of 1-5. Analysts mean target price for Abaxis, Inc. (NASDAQ:ABAX) is $48.79 while their mean recommendation is 3.10 (1=Buy, 5=sell).

Roka Bioscience, Inc. (NASDAQ:ROKA) shares moved to $6.00 after starting the day at $5.72 on Tuesday. Weekly volatility of ROKA is 14.02% and monthly volatility is 8.98%. Stock performance in last five sessions is recorded as 39.86% while year to date (YTD) performance is 41.51%. ROKA Gross Margin is -23.20% and its return on assets is -53.30%. Stock 3 months performance is recorded as -18.92%.

Analyst Rating on Roka Bioscience, Inc. (NASDAQ:ROKA)

Number of analysts are covering this stock and currently stock has got OUTPERFORM rating from 1 analyst of Thomson Reuters, no analyst given HOLD rating to the stock and 0  given UNDERPERFORM rating. Analyst’s mean target price for ROKA is $10.00 while analysts mean recommendation is 2.00.

EOG Resources, Inc. (NYSE:EOG) has declared a dividend of $0.1675 per share on EOG’s Common Stock, payable January 31, 2017, to stockholders of record as of January 17, 2017. The indicated annual rate is $0.67.

EOG Resources, Inc. (NYSE:EOG) traded 2.91 Million shares and was closed at $103.40 per share. The current share price indicate that stock is -5.46% away from its one year high and is moving 82.00% ahead of its one year low. Stock monthly performance is recorded as -1.46% while its performance in last 5 sessions is -0.14%.

Analyst’s Analysis on EOG Resources, Inc. (NYSE:EOG)

At the movement stock is under coverage by number of analysts. At the movement stock is under coverage by number of analysts. 12 given Buy rating to the stock whereas no analyst given UNDERPERFORM rating to stock and 19 analysts given HOLD rating. The consensus recommendation by Thomson Reuters analysts is Outperform and their mean rating for the stock is 2.17 on scale of 1-5. Analysts mean target price for EOG Resources, Inc. (NYSE:EOG) is $110.36 while their mean recommendation is 2.20 (1=Buy, 5=sell).

Timmins Gold Corp. (NYSE:TGD) shares moved to $0.33 after starting the day at $0.3355 on Tuesday. Weekly volatility of TGD is 5.90% and monthly volatility is 7.39%. Stock performance in last five sessions is recorded as 0.55% while year to date (YTD) performance is 4.61%. Firm quarterly performance is -26.54%.

Analyst Recommendation on Timmins Gold Corp. (NYSE:TGD)

Number of analysts are covering this stock and currently stock has got OUTPERFORM rating from 4 analysts of Thomson Reuters, 2 analysts given HOLD rating to the stock and 0 given UNDERPERFORM rating to Timmins Gold Corp. (NYSE:TGD) stock. Analyst’s mean target price for TGD is $40.90 while analysts mean recommendation is 2.30.

Leave a Reply

Your email address will not be published. Required fields are marked *